The advancements in developing a COVID-19 vaccine continue from Rees Scientific customers. Recently, Pfizer and BioNTech announced early positive data from an ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2.
View the full news release, here.
Rees Scientific provides continuous automated monitoring to a limitless number of applications in a wide range of industries. From Pharmaceutical to Blood Banking, Laboratory Animal Research to Biotech and Hospitals, Rees Scientific has become the standard by which other monitoring systems are judged.
